|
Volumn 44, Issue 6, 2010, Pages 459-460
|
How to manage helicobacter pylori after sequential therapy failure?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
CLARITHROMYCIN;
LANSOPRAZOLE;
LEVOFLOXACIN;
METRONIDAZOLE;
PROTON PUMP INHIBITOR;
RABEPRAZOLE;
TINIDAZOLE;
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
ANTIINFECTIVE AGENT;
ENZYME INHIBITOR;
OFLOXACIN;
ANTIBIOTIC THERAPY;
HELICOBACTER INFECTION;
LETTER;
NONHUMAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
TREATMENT FAILURE;
ADULT;
AGED;
CHILD;
CLINICAL TRIAL (TOPIC);
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECTS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMAN;
MICROBIOLOGY;
TREATMENT OUTCOME;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
AGED;
AMOXICILLIN;
ANTI-BACTERIAL AGENTS;
CHILD;
CLINICAL TRIALS AS TOPIC;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
OFLOXACIN;
TREATMENT FAILURE;
TREATMENT OUTCOME;
LANSOPRAZOLE;
RABEPRAZOLE;
|
EID: 77953771375
PISSN: 01920790
EISSN: None
Source Type: Journal
DOI: 10.1097/MCG.0b013e3181d06b41 Document Type: Letter |
Times cited : (10)
|
References (5)
|